MENU
MREO Mereo BioPharma Group plc Chart, History Price & Graph
a company, which engages in therapeutics that aim to improve outcomes for patients with osteogenesis imperfecta, alpha-1 antitrypsin deficiency, hypogonadotropic hypogonadism in obese men, and acute exacerbations of chronic obstructive pulmonary disease
Industry Biotechnology
Show more...
A.I.Advisor
published price charts
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
MREO and Stocks
Correlation & Price change
A.I.dvisor indicates that over the last year, MREO has been loosely correlated with TERN. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if MREO jumps, then TERN could also see price increases.
1D
1W
1M
1Q
6M
1Y
5Y
| Ticker / NAME | Correlation To MREO | 1D Price Change % | ||
|---|---|---|---|---|
| MREO | 100% | -1.45% | ||
| TERN - MREO | 36% Loosely correlated | -2.58% | ||
| INZY - MREO | 34% Loosely correlated | -2.65% | ||
| URGN - MREO | 33% Poorly correlated | +0.27% | ||
| RNA - MREO | 31% Poorly correlated | -1.95% | ||
| ACLX - MREO | 30% Poorly correlated | -1.67% | ||
More | ||||